Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-30

Clinical Trial Update: Effects of Micronutrient (Chromium) Supplementation on Diabetes [NA]

View source ↗

Summary

A completed clinical trial evaluating chromium micronutrient supplementation in type 1 diabetes; results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chromium supplement (chromium)

Snippet

Sponsor: Louisiana State University Health Sciences Center Shreveport | Conditions: Diabetes Mellitus, Type 1 | NA | Status: COMPLETED | Results posted: 2022-06-30